Rockwell Medical (RMTI) Change in Accured Expenses (2010 - 2026)

Rockwell Medical has reported Change in Accured Expenses for 17 years, with the latest figure at -$1.5 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Accured Expenses rose 11.97% year-over-year to -$1.5 million; the trailing twelve-month figure through Mar 2026 stood at -$1.5 million (down 95.25% YoY), and the FY2025 full-year result was -$1.7 million, down 62.38% from the prior year.
• Change in Accured Expenses for Q1 2026 stood at -$1.5 million, down from $625000.0 in the prior quarter.
• The five-year high for Change in Accured Expenses was $2.9 million in Q3 2023, with the low at -$3.3 million in Q1 2023.
• Historically, Change in Accured Expenses has averaged -$118705.9 across 5 years, with a median of -$139000.0 in 2025.
• Annual changes were most pronounced in 2023 — Change in Accured Expenses tumbled 414.84% — and 2025, when it soared 320.85%.
• Rockwell Medical's Change in Accured Expenses stood at $1.8 million in 2022, then plunged by 63.05% to $657000.0 in 2023, then plunged by 143.07% to -$283000.0 in 2024, then soared by 320.85% to $625000.0 in 2025, then sank by 334.08% to -$1.5 million in 2026.
• The last three Change in Accured Expenses figures came in at -$1.5 million (Q1 2026), $625000.0 (Q4 2025), and -$139000.0 (Q3 2025), per Business Quant data.